Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | DNM2 | P50570 | 9/20 | 0.49 |
| ▸ | KCNH3 | Q9ULD8 | 2/20 | 0.49 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.38 |
| ▸ | MMP3 | P08254 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2830470 | 1.00 | KMT2A (0.53) | KMT2ADNM2KCNH3SLC29A1MAPT | |
| SCHEMBL21295420 | 1.00 | KMT2A (0.53) | KMT2ADNM2KCNH3SLC29A1MAPT | |
| SCHEMBL31539940 | 1.00 | KMT2A (0.53) | KMT2ADNM2KCNH3SLC29A1MAPT | |
| SCHEMBL31539938 | 1.00 | KMT2A (0.53) | KMT2ADNM2KCNH3SLC29A1MAPT | |
| SCHEMBL29025224 | 1.00 | KMT2A (0.53) | KMT2ADNM2KCNH3SLC29A1MAPT | |
| SCHEMBL2570949 | 1.00 | KMT2A (0.53) | KMT2ADNM2KCNH3SLC29A1MAPT | |
| SCHEMBL1151635 | 1.00 | KMT2A (0.53) | KMT2ADNM2KCNH3SLC29A1MAPT | |
| SCHEMBL1152303 | 0.98 | KMT2A (0.51) | KMT2ADNM2KCNH3SLC29A1MAPT | |
| SCHEMBL6421283 | 0.98 | KMT2A (0.51) | KMT2ADNM2KCNH3SLC29A1MAPT | |
| Potassium SCHEMBL29627320 | 0.98 | KMT2A (0.51) | KMT2ADNM2KCNH3SLC29A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230101743-A1 | SUBSTITUTED TRIAZINE COMPOUNDS AND USES THEREOF | MUSC FOUNDATION FOR RESEARCH DEVELOPMENT | 2023-03-30 | — | — | US | claimed |
| EP-4087837-A1 | SUBSTITUTED TRIAZINE COMPOUNDS AND USES THEREOF | Musc Foundation for Research Development (US) | 2022-11-16 | — | — | EP | claimed |
| US-8420738-B2 | Thermoplastic elastomer composition and production process | SUMITOMO RUBBER INDUSTRIES, LTD. (JP) | 2013-04-16 | — | — | US | claimed |
| US-12622985-B2 | Sterilization method for medical rubber part | SUMITOMO RUBBER INDUSTRIES, LTD. (JP) | 2026-05-12 | — | — | US | disclosed |
| EP-4201434-B1 | MEDICAL RUBBER COMPOSITION, MEDICAL RUBBER PART, AND PACKAGING ARTICLE FOR MEDICAL RUBBER PART | SUMITOMO RUBBER IND (JP) | 2026-05-06 | — | — | EP | disclosed |
| EP-3824914-B1 | MEDICAL RUBBER COMPOSITION AND MEDICAL RUBBER COMPONENT | SUMITOMO RUBBER IND (JP) | 2026-04-29 | — | — | EP | disclosed |
| EP-4360662-B1 | STERILIZATION METHOD FOR MEDICAL RUBBER PART | SUMITOMO RUBBER IND (JP) | 2026-04-29 | — | — | EP | disclosed |
| US-20260098145-A1 | RUBBER COMPOSITION AND RUBBER | TOAGOSEI CO., LTD. (JP) | 2026-04-09 | — | — | US | disclosed |
| US-12577377-B2 | Medical rubber composition, medical rubber part, and packaging article for medical rubber part | SUMITOMO RUBBER INDUSTRIES, LTD. (JP) | 2026-03-17 | — | — | US | disclosed |
| EP-4450556-B1 | MEDICAL RUBBER COMPOSITION AND MEDICAL RUBBER PRODUCT | SUMITOMO RUBBER IND (JP) | 2026-01-28 | — | — | EP | disclosed |
| US-20250282932-A1 | RUBBER COMPOSITION AND METHOD FOR PRODUCING SAME | TOAGOSEI CO., LTD. (JP) | 2025-09-11 | — | — | US | disclosed |
| EP-2597047-B1 | Thermoplastic elastomer composition and medical rubber product | SUMITOMO RUBBER IND (JP) | 2015-07-01 | — | — | EP | disclosed |
| US-8962758-B2 | Thermoplastic elastomer composition and medical rubber product | SUMITOMO RUBBER INDUSTRIES, LTD. (JP) | 2015-02-24 | — | — | US | disclosed |
| CN-103131094-A | Thermoplastic elastomer composition and medical rubber product | SUMITOMO RUBBER IND | 2013-06-05 | — | — | CN | disclosed |
| US-20130137825-A1 | THERMOPLASTIC ELASTOMER COMPOSITION AND MEDICAL RUBBER PRODUCT | SUMITOMO RUBBER INDUSTRIES, LTD. (JP) | 2013-05-30 | — | — | US | disclosed |
| EP-2597047-A1 | Thermoplastic elastomer composition and medical rubber product | Sumitomo Rubber Industries, Ltd. (JP) | 2013-05-29 | — | — | EP | disclosed |
| US-8420738-B2 | Thermoplastic elastomer composition and production process | SUMITOMO RUBBER INDUSTRIES, LTD. (JP) | 2013-04-16 | — | — | US | disclosed |
| EP-2208753-B1 | THERMOPLASTIC ELASTOMER COMPOSITION AND PRODUCTION PROCESS | SUMITOMO RUBBER IND (JP) | 2012-09-05 | — | — | EP | disclosed |
| US-20100267899-A1 | THERMOPLASTIC ELASTOMER COMPOSITION AND PRODUCTION PROCESS | SUMITOMO RUBBER INDUSTRIES, LTD (JP) | 2010-10-21 | — | — | US | disclosed |
| EP-2208753-A1 | THERMOPLASTIC ELASTOMER COMPOSITION AND PRODUCTION PROCESS | Sumitomo Rubber Industries, Ltd. (JP) | 2010-07-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12622985-B2 | Sterilization method for medical rubber part | TMEM97, SEC61A1, SQLE | KMT2A 2326/4885DNM2 4628/4885KCNH3 2031/4885 |
| US-20260098145-A1 | RUBBER COMPOSITION AND RUBBER | CROCC, RPL30, RPL29 | KMT2A 1082/4885DNM2 3877/4885KCNH3 1672/4885 |
| US-20230101743-A1 | SUBSTITUTED TRIAZINE COMPOUNDS AND USES THEREOF | PCSK9, SLC10A1, CYP3A5 | KMT2A 1500/4885DNM2 3613/4885KCNH3 1770/4885 |
| US-12577377-B2 | Medical rubber composition, medical rubber part, and packaging article for medical rubber part | LBR, XRCC5, DHCR24 | KMT2A 3531/4885DNM2 4693/4885KCNH3 3455/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.